{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T12:19:10Z","timestamp":1788956350443,"version":"build-2803163510"},"update-to":[{"DOI":"10.1371\/journal.pntd.0009489","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T00:00:00Z","timestamp":1624406400000}}],"reference-count":84,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T00:00:00Z","timestamp":1623369600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000200","name":"United States Agency for International Development","doi-asserted-by":"publisher","award":["AID-OAA-G14-00010"],"award-info":[{"award-number":["AID-OAA-G14-00010"]}],"id":[{"id":"10.13039\/100000200","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000200","name":"United States Agency for International Development","doi-asserted-by":"publisher","award":["AID-OAA-G14-00010"],"award-info":[{"award-number":["AID-OAA-G14-00010"]}],"id":[{"id":"10.13039\/100000200","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000200","name":"United States Agency for International Development","doi-asserted-by":"publisher","award":["AID-OAA-G14-00010"],"award-info":[{"award-number":["AID-OAA-G14-00010"]}],"id":[{"id":"10.13039\/100000200","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000200","name":"United States Agency for International Development","doi-asserted-by":"publisher","award":["AID-OAA-G14-00010"],"award-info":[{"award-number":["AID-OAA-G14-00010"]}],"id":[{"id":"10.13039\/100000200","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1184344"],"award-info":[{"award-number":["OPP1184344"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1184344"],"award-info":[{"award-number":["OPP1184344"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1184344"],"award-info":[{"award-number":["OPP1184344"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003246","name":"Dutch Research Council","doi-asserted-by":"crossref","award":["016.Veni.178.023"],"award-info":[{"award-number":["016.Veni.178.023"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"crossref"}]},{"name":"World Health Organization\/Special Programme for Research and Training in Tropical Diseases","award":["unknown"],"award-info":[{"award-number":["unknown"]}]}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>Onchocerciasis (river-blindness) in Africa is targeted for elimination through mass drug administration (MDA) with ivermectin. Onchocerciasis may cause various types of skin and eye disease. Predicting the impact of MDA on onchocercal morbidity is useful for future policy development. Here, we introduce a new disease module within the established ONCHOSIM model to predict trends over time in prevalence of onchocercal morbidity.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>We developed novel generic model concepts for development of symptoms due to cumulative exposure to dead microfilariae, accommodating both reversible (acute) and irreversible (chronic) symptoms. The model was calibrated to reproduce pre-control age patterns and associations between prevalences of infection, eye disease, and various types of skin disease as observed in a large set of population-based studies. We then used the new disease module to predict the impact of MDA on morbidity prevalence over a 30-year time frame for various scenarios.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>ONCHOSIM reproduced observed age-patterns in disease and community-level associations between infection and disease reasonably well. For highly endemic settings with 30 years of annual MDA at 60% coverage, the model predicted a 70% to 89% reduction in prevalence of chronic morbidity. This relative decline was similar with higher MDA coverage and only somewhat higher for settings with lower pre-control endemicity. The decline in prevalence was lowest for mild depigmentation and visual impairment. The prevalence of acute clinical manifestations (severe itch, reactive skin disease) declined by 95% to 100% after 30 years of annual MDA, regardless of pre-control endemicity.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusion<\/jats:title>\n<jats:p>We present generic model concepts for predicting trends in acute and chronic symptoms due to history of exposure to parasitic worm infections, and apply this to onchocerciasis. Our predictions suggest that onchocercal morbidity, in particular chronic manifestations, will remain a public health concern in many epidemiological settings in Africa, even after 30 years of MDA.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pntd.0009489","type":"journal-article","created":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T17:42:55Z","timestamp":1623433375000},"page":"e0009489","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":16,"title":["How does onchocerciasis-related skin and eye disease in Africa depend on cumulative exposure to infection and mass treatment?"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1494-3101","authenticated-orcid":true,"given":"Natalie V. S.","family":"Vinkeles Melchers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9509-1328","authenticated-orcid":true,"given":"Wilma A.","family":"Stolk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0798-9371","authenticated-orcid":true,"given":"Michele E.","family":"Murdoch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bel\u00e9n","family":"Pedrique","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5574-3499","authenticated-orcid":true,"given":"Marielle","family":"Kloek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1958-0944","authenticated-orcid":true,"given":"Roel","family":"Bakker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1830-5668","authenticated-orcid":true,"given":"Sake J.","family":"de Vlas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4425-2264","authenticated-orcid":true,"given":"Luc E.","family":"Coffeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2021,6,11]]},"reference":[{"key":"pntd.0009489.ref001","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1128\/CMR.12.3.445","article-title":"Pathogenesis of onchocercal keratitis (river blindness).","volume":"12","author":"LR Hall","year":"1999","journal-title":"Clin Microbiol Rev"},{"key":"pntd.0009489.ref002","first-page":"781","author":"J Bradley","year":"2005","journal-title":"Onchocerciasis. Parasitology"},{"key":"pntd.0009489.ref003","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0001-706X(91)90015-C","article-title":"The reproductive lifespan of Onchocerca volvulus in West African savanna","volume":"48","author":"AP Plaisier","year":"1991","journal-title":"Acta Trop"},{"key":"pntd.0009489.ref004","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1128\/CMR.00057-10","article-title":"Onchocerciasis: the role of Wolbachia bacterial endosymbionts in parasite biology, disease pathogenesis, and treatment","volume":"24","author":"F Tamarozzi","year":"2011","journal-title":"Clin Microbiol Rev"},{"key":"pntd.0009489.ref005","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1093\/clinids\/7.6.802","article-title":"Variations in host responses and the pathogenesis of human onchocerciasis","volume":"7","author":"CD Mackenzie","year":"1985","journal-title":"Rev Infect Dis"},{"key":"pntd.0009489.ref006","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1086\/315041","article-title":"Eotaxin expression in Onchocerca volvulus-induced dermatitis after topical application of diethylcarbamazine","volume":"180","author":"E Pearlman","year":"1999","journal-title":"J Infect Dis"},{"key":"pntd.0009489.ref007","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1086\/367709","article-title":"Immune responses directed against microfilariae correlate with severity of clinical onchodermatitis and treatment history","volume":"187","author":"MM Ali","year":"2003","journal-title":"J Infect Dis"},{"key":"pntd.0009489.ref008","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1365-2133.1993.tb11844.x","article-title":"A clinical classification and grading system of the cutaneous changes in onchocerciasis","volume":"129","author":"ME Murdoch","year":"1993","journal-title":"Br J Derm"},{"key":"pntd.0009489.ref009","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/0035-9203(86)90129-X","article-title":"The burden of blindness in adult males in the savanna villages of West Africa exposed to onchocerciasis","volume":"80","author":"A Prost","year":"1986","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"pntd.0009489.ref010","first-page":"773","article-title":"[Excess mortality among blind persons in the West African savannah zone].","volume":"59","author":"A Prost","year":"1981","journal-title":"Bull World Heal Organ"},{"key":"pntd.0009489.ref011","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1179\/000349802125000718","article-title":"Excess mortality associated with blindness in the onchocerciasis focus of the Mbam Valley, Cameroon","volume":"96","author":"SDS Pion","year":"2002","journal-title":"Ann Trop Med Parasitol"},{"key":"pntd.0009489.ref012","first-page":"513","article-title":"Elimination of human onchocerciasis: progress report, 2018\u20132019","volume":"95","author":"World Health Organization","year":"2019","journal-title":"Wkly Epidemiol Rec World Heal Organ"},{"key":"pntd.0009489.ref013","first-page":"e0004328","article-title":"Model-Based Geostatistical Mapping of the Prevalence of Onchocerca volvulus in West Africa","volume":"10","author":"SJ O\u2019Hanlon","year":"2016","journal-title":"PLoS Med"},{"key":"pntd.0009489.ref014","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1186\/1756-3305-7-326","article-title":"The geographic distribution of onchocerciasis in the 20 participating countries of the African Programme for Onchocerciasis Control: (2) pre-control endemicity levels and estimated number infected","volume":"7","author":"HHGM Zour\u00e9","year":"2014","journal-title":"Parasit Vectors"},{"key":"pntd.0009489.ref015","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1093\/infdis\/172.1.204","article-title":"Irreversible effects of ivermectin on adult parasites in onchocerciasis patients in the Onchocerciasis Control Programme in West Africa","volume":"172","author":"AP Plaisier","year":"1995","journal-title":"J Infect Dis"},{"key":"pntd.0009489.ref016","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.4269\/ajtmh.2005.73.1159","article-title":"Short report: impact of ivermectin community-level treatments on elimination of adult Onchocerca volvulus when individuals receive multiple treatments per year","volume":"73","author":"EW Cupp","year":"2005","journal-title":"Am J Trop Med Hyg"},{"key":"pntd.0009489.ref017","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0140-6736(02)09456-4","article-title":"Demanga-Ngangue, Duke BOL. Effects of standard and high doses of ivermectin on adult worms of Onchocerca volvulus: a randomised controlled trial","volume":"360","author":"J Gardon","year":"2002","journal-title":"Lancet"},{"key":"pntd.0009489.ref018","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1093\/cid\/cix616","article-title":"Macrofilaricidal Efficacy of Repeated Doses of Ivermectin for the Treatment of River Blindness","volume":"65","author":"M Walker","year":"2017","journal-title":"Clin Infect Dis"},{"key":"pntd.0009489.ref019","author":"World Health Organization","year":"2012","journal-title":"Accelerating work to overcome the global impact of neglected tropical diseases\u2014a roadmap for implementation"},{"key":"pntd.0009489.ref020","first-page":"e497","article-title":"Feasibility of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: first evidence from studies in Mali and Senegal","volume":"3","author":"L Diawara","year":"2009"},{"key":"pntd.0009489.ref021","first-page":"e1825","article-title":"Proof-of-principle of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: final results of a study in Mali and Senegal.","volume":"6","author":"MO Traore","year":"2012"},{"key":"pntd.0009489.ref022","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1756-3305-5-28","article-title":"Impact of long-term treatment of onchocerciasis with ivermectin in Kaduna State, Nigeria: first evidence of the potential for elimination in the operational area of the African Programme for Onchocerciasis Control","volume":"5","author":"AH Tekle","year":"2012","journal-title":"Parasit Vectors"},{"key":"pntd.0009489.ref023","unstructured":"African Programme for Onchocerciasis Control. Conceptual and operational framework of onchocerciasis elimination with ivermectin treatment. Ouagadougou; 2010. Available: https:\/\/www.who.int\/apoc\/oncho_elimination_report_english.pdf"},{"key":"pntd.0009489.ref024","first-page":"360","author":"J Habbema","year":"1996"},{"key":"pntd.0009489.ref025","doi-asserted-by":"crossref","first-page":"e115886","DOI":"10.1371\/journal.pone.0115886","article-title":"Elimination of African onchocerciasis: modeling the impact of increasing the frequency of ivermectin mass treatment","volume":"9","author":"LE Coffeng","year":"2014","journal-title":"PLoS One"},{"key":"pntd.0009489.ref026","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1186\/s13071-015-1159-9","article-title":"Required duration of mass ivermectin treatment for onchocerciasis elimination in Africa: a comparative modelling analysis","volume":"8","author":"WA Stolk","year":"2015","journal-title":"Parasit Vectors"},{"key":"pntd.0009489.ref027","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/1756-3305-7-241","article-title":"Modelling the impact of ivermectin on River Blindness and its burden of morbidity and mortality in African Savannah: EpiOncho projections","volume":"7","author":"HC Turner","year":"2014","journal-title":"Parasit Vectors"},{"key":"pntd.0009489.ref028","doi-asserted-by":"crossref","first-page":"e0003664","DOI":"10.1371\/journal.pntd.0003664","article-title":"Control, elimination, and eradication of river blindness: scenarios, timelines, and ivermectin treatment needs in Africa","volume":"9","author":"YE Kim","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0009489.ref029","doi-asserted-by":"crossref","first-page":"e000158","DOI":"10.1136\/bmjgh-2016-000158","article-title":"Modelling the health and economic impacts of the elimination of river blindness (onchocerciasis) in Africa.","volume":"2","author":"YE Kim","year":"2017","journal-title":"BMJ Glob Heal"},{"key":"pntd.0009489.ref030","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0169-2607(90)90030-D","article-title":"ONCHOSIM: a model and computer simulation program for the transmission and control of onchocerciasis","volume":"31","author":"AP Plaisier","year":"1990","journal-title":"Comput Methods Programs Biomed"},{"key":"pntd.0009489.ref031","first-page":"17","author":"A Plaisier","year":"1996"},{"key":"pntd.0009489.ref032","doi-asserted-by":"crossref","first-page":"A45","DOI":"10.1111\/j.1365-3156.2004.01213.x","article-title":"Impact of ivermectin on illness and disability associated with onchocerciasis","volume":"9","author":"JM Tielsch","year":"2004","journal-title":"Trop Med Int Heal"},{"key":"pntd.0009489.ref033","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/infdis\/163.2.381","article-title":"Community-based treatment of onchocerciasis with ivermectin: Safety, efficacy, and acceptability of yearly treatment","volume":"163","author":"M Pacqu\u00e9","year":"1991","journal-title":"J Infect Dis"},{"key":"pntd.0009489.ref034","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/0035-9203(92)90182-C","article-title":"Adverse reactions after community treatment of onchocerciasis with ivermectin in guatemala","volume":"86","author":"R Zea-Flores","year":"1992","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"pntd.0009489.ref035","first-page":"25","article-title":"Migration and death of skin-dwelling Onchocerca volvulus microfilariae after treatment with ivermectin","volume":"42","author":"BOL Duke","year":"1991","journal-title":"Trop Med Parasitol"},{"key":"pntd.0009489.ref036","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1001\/archopht.1986.01050180097039","article-title":"Treatment of onchocerciasis. The ocular effects of ivermectin and diethylcarbamazine","volume":"104","author":"HR Taylor","year":"1986","journal-title":"Arch Ophthalmol"},{"key":"pntd.0009489.ref037","doi-asserted-by":"crossref","first-page":"29089","DOI":"10.1371\/journal.pone.0029089","article-title":"Evolutionary determinants of genetic variation in susceptibility to infectious diseases in humans","volume":"7","author":"C Baker","year":"2012","journal-title":"PLoS One"},{"key":"pntd.0009489.ref038","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/emmm.201000111","article-title":"Copy number variation and susceptibility to complex traits","volume":"3","author":"CP Canales","year":"2011","journal-title":"EMBO Mol Med"},{"key":"pntd.0009489.ref039","doi-asserted-by":"crossref","first-page":"e2032","DOI":"10.1371\/journal.pntd.0002032","article-title":"African Programme for Onchocerciasis Control 1995\u20132015: model-estimated health impact and cost","volume":"7","author":"LE Coffeng","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0009489.ref040","first-page":"263","article-title":"The effect of 7\u20138 years of vector control on the evolution of ocular onchocerciasis in West African savanna","volume":"37","author":"KY Dadzie","year":"1986","journal-title":"Trop Med Parasitol"},{"key":"pntd.0009489.ref041","first-page":"371","article-title":"Structure of the collagen nodule from hypertrophic scars and keloids","author":"CW Kischer","year":"1981","journal-title":"Scan Electron Microsc"},{"key":"pntd.0009489.ref042","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1179\/000349802125000826","article-title":"Onchocerciasis: the clinical and epidemiological burden of skin disease in Africa","volume":"96","author":"ME Murdoch","year":"2002","journal-title":"Ann Trop Med Parasitol"},{"key":"pntd.0009489.ref043","doi-asserted-by":"crossref","first-page":"e2168","DOI":"10.1371\/journal.pntd.0002168","article-title":"Onchocerciasis: the pre-control association between prevalence of palpable nodules and skin microfilariae","volume":"7","author":"LE Coffeng","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0009489.ref044","unstructured":"WHO. WHO Study Group on the Prevention of Blindness & World Health Organization. The prevention of blindness: report of a WHO Study Group [meeting held in Geneva from 6 to 10 November 1972]. World Health Organization. 1973."},{"key":"pntd.0009489.ref045","doi-asserted-by":"crossref","first-page":"e888","DOI":"10.1016\/S2214-109X(17)30293-0","article-title":"Magnitude, temporal trends, and projections of the global prevalence of blindness and distance and near vision impairment: a systematic review and meta-analysis","volume":"5","author":"RRA Bourne","year":"2017","journal-title":"Lancet Glob Heal"},{"key":"pntd.0009489.ref046","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1080\/00034983.1966.11686422","article-title":"Onchocerca-Simulium complexes. I. Transmission of forest and Sudan-savanna strains of Onchocerca volvulus, from Cameroon, by Simulium damnosum from various West African bioclimatic zones","volume":"60","author":"BO Duke","year":"1966","journal-title":"Ann Trop Med Parasitol"},{"key":"pntd.0009489.ref047","first-page":"340","article-title":"Ocular onchocerciasis and intensity of infection in the community. I. West African savanna","volume":"40","author":"J Remme","year":"1989","journal-title":"Trop Med Parasitol"},{"key":"pntd.0009489.ref048","volume-title":"The Global Burden of Onchocerciasis in 1990","author":"JHF Remme","year":"2004"},{"key":"pntd.0009489.ref049","first-page":"137","article-title":"Prevalence, intensity and ocular manifestations of Onchocerca volvulus infection in Dimbelenge, Zaire.","volume":"69","author":"R Brown","year":"1989","journal-title":"Ann Soc Belg Med Trop (1920)."},{"key":"pntd.0009489.ref050","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1080\/00034983.1990.11812500","article-title":"The onchocerciasis focus at Kinsuka\/Kinshasa (Republic of Zaire) in 1985. II. Parasitological and clinical aspects","volume":"84","author":"MC Henry","year":"1990","journal-title":"Ann Trop Med Parasitol"},{"key":"pntd.0009489.ref051","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/0140-6736(91)91963-U","article-title":"Effects of repeated doses of ivermectin on ocular onchocerciasis: community-based trial in Sierra Leone","volume":"338","author":"JA Whitworth","year":"1991","journal-title":"Lancet"},{"key":"pntd.0009489.ref052","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1136\/bjo.77.1.30","article-title":"Visual loss in an onchocerciasis endemic community in Sierra Leone","volume":"77","author":"JA Whitworth","year":"1993","journal-title":"Br J Ophthalmol"},{"key":"pntd.0009489.ref053","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1046\/j.1365-3156.2003.00957.x","article-title":"Profile of eye lesions and vision loss: a cross-sectional study in Lusambo, a forest-savanna area hyperendemic for onchocerciasis in the Democratic Republic of Congo","volume":"8","author":"DL Kayembe","year":"2003","journal-title":"Trop Med Int Health"},{"key":"pntd.0009489.ref054","first-page":"844","article-title":"Global data on visual impairment in the year 2002","volume":"82","author":"S Resnikoff","year":"2004","journal-title":"Bull World Health Organ"},{"key":"pntd.0009489.ref055","first-page":"376","article-title":"Ocular onchocerciasis and intensity of infection in the community. III. West African rainforest foci of the vector Simulium sanctipauli","volume":"41","author":"KY Dadzie","year":"1990","journal-title":"Trop Med Parasitol"},{"key":"pntd.0009489.ref056","first-page":"75","article-title":"Ocular onchocerciasis and the intensity of infection in the community. IV. The degraded forest of Sierra Leone","volume":"43","author":"KY Dadzie","year":"1992","journal-title":"Trop Med Parasitol"},{"key":"pntd.0009489.ref057","first-page":"348","article-title":"Ocular onchocerciasis and intensity of infection in the community. II. West African rainforest foci of the vector Simulium yahense","volume":"40","author":"KY Dadzie","year":"1989","journal-title":"Trop Med Parasitol"},{"key":"pntd.0009489.ref058","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1046\/j.1365-3156.1998.00339.x","article-title":"The effects of ivermectin on onchocercal skin disease and severe itching: results of a multicentre trial","volume":"3","author":"WR Brieger","year":"1998","journal-title":"Trop Med Int Heal"},{"key":"pntd.0009489.ref059","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/j.1365-3156.2011.02783.x","article-title":"The African Programme for Onchocerciasis Control: impact on onchocercal skin disease","volume":"16","author":"GA Ozoh","year":"2011","journal-title":"Trop Med Int Heal"},{"key":"pntd.0009489.ref060","first-page":"CD002219","article-title":"Ivermectin for onchocercal eye disease (river blindness).","author":"HO Ejere","year":"2001","journal-title":"Cochrane Database Syst Rev"},{"key":"pntd.0009489.ref061","doi-asserted-by":"crossref","first-page":"e0005489","DOI":"10.1371\/journal.pntd.0005489","article-title":"Pre-control relationship of onchocercal skin disease with onchocercal infection in Guinea Savanna, Northern Nigeria.","volume":"11","author":"ME Murdoch","year":"2017","journal-title":"PLoS Negl Trop Dis."},{"key":"pntd.0009489.ref062","first-page":"843","article-title":"Predictive Value of Ov16 Antibody Prevalence in Different Sub-Populations for Elimination of African Onchocerciasis","volume":"351","author":"LE Coffeng","year":"2019","journal-title":"Am J Epidemiol"},{"key":"pntd.0009489.ref063","author":"WHO","year":"2001"},{"key":"pntd.0009489.ref064","first-page":"655","article-title":"The degrees of endemicity of onchocerciasis.","volume":"57","author":"A Prost","year":"1979","journal-title":"Bull World Heal Organ"},{"key":"pntd.0009489.ref065","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/327415a0","article-title":"A DNA sequence specific for forest form Onchocerca volvulus","volume":"327","author":"KD Erttmann","year":"1987","journal-title":"Nature"},{"key":"pntd.0009489.ref066","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1093\/infdis\/165.5.964","article-title":"Onchocerca volvulus DNA probe classification correlates with epidemiologic patterns of blindness","volume":"165","author":"PA Zimmerman","year":"1992","journal-title":"J Infect Dis"},{"key":"pntd.0009489.ref067","doi-asserted-by":"crossref","first-page":"556","DOI":"10.4269\/ajtmh.2004.70.556","article-title":"A longitudinal study of impact of repeated mass ivermectin treatment on clinical manifestations of onchocerciasis in Imo State, Nigeria","volume":"70","author":"EC Emukah","year":"2004","journal-title":"Am J Trop Med Hyg"},{"key":"pntd.0009489.ref068","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1111\/j.1365-3156.2008.02126.x","article-title":"After a decade of annual dose mass ivermectin treatment in Cameroon and Uganda, onchocerciasis transmission continues","volume":"13","author":"M Katabarwa","year":"2008","journal-title":"Trop Med Int Heal"},{"key":"pntd.0009489.ref069","doi-asserted-by":"crossref","first-page":"S510","DOI":"10.1093\/infdis\/jiz674","article-title":"Structural uncertainty in onchocerciasis transmission models influences the estimation of elimination thresholds and selection of age groups for seromonitoring","volume":"221","author":"JID Hamley","year":"2020","journal-title":"J Infect Dis"},{"key":"pntd.0009489.ref070","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/S0140-6736(17)32844-1","article-title":"Single dose moxidectin versus ivermectin for Onchocerca volvulus infection in Ghana, Liberia, and the Democratic Republic of the Congo: a randomised, controlled, double-blind phase 3 trial","volume":"392","author":"NO Opoku","year":"2018","journal-title":"Lancet"},{"key":"pntd.0009489.ref071","doi-asserted-by":"crossref","first-page":"243","DOI":"10.4269\/ajtmh.1995.53.243","article-title":"Evaluation of alternate methods of rapid assessment of endemicity of Onchocerca volvulus in communities in southern Cameroon","volume":"53","author":"B Kollo","year":"1995","journal-title":"Am J Trop Med Hyg"},{"key":"pntd.0009489.ref072","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1093\/ije\/16.4.590","article-title":"\u201cLeopard Skin\u201d as a rapid diagnostic index for estimating the endemicity of African onchocerciasis","volume":"16","author":"L Edungbola","year":"1987","journal-title":"Int J Epidemiol"},{"key":"pntd.0009489.ref073","first-page":"755","article-title":"Prevalence of depigmentation of the shins: a simple and cheap way to screen for severe endemic onchocerciasis in Africa.","volume":"72","author":"B Carme","year":"1994","journal-title":"Bull World Heal Organ"},{"key":"pntd.0009489.ref074","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0035-9203(74)90117-5","article-title":"Marshall TF. Studies on onchocerciasis in the United Cameroon Republic II. Comparison of onchocerciasis in rain-forest and Sudan-savanna","volume":"68","author":"J Anderson","year":"1974","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"pntd.0009489.ref075","first-page":"37","article-title":"Ocular onchocerciasis\u2014the effects of six years of treatment with ivermectin","author":"D Mabey","year":"1996","journal-title":"IOVS"},{"key":"pntd.0009489.ref076","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1076\/opep.6.4.229.4185","article-title":"Effect of repeated ivermectin treatments on ocular onchocerciasis: Evaluation after six to eight dosings.","volume":"6","author":"JP Chippaux","year":"1999","journal-title":"Ophthalmic Epidemiol"},{"key":"pntd.0009489.ref077","doi-asserted-by":"crossref","first-page":"e98411","DOI":"10.1371\/journal.pone.0098411","article-title":"Sustainable control of onchocerciasis: ocular pathology in onchocerciasis patients treated annually with ivermectin for 23 years: a cohort study","volume":"9","author":"M Banla","year":"2014","journal-title":"PLoS One"},{"key":"pntd.0009489.ref078","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/0140-6736(93)90002-X","article-title":"Reduction in Incidence of Optic-Nerve Disease with Annual Ivermectin to Control Onchocerciasis","volume":"341","author":"A Abiose","year":"1993","journal-title":"Lancet"},{"key":"pntd.0009489.ref079","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/0035-9203(91)90236-R","article-title":"A community trial of ivermectin for onchocerciasis in Sierra Leone: Adverse reactions after the first five treatment rounds","volume":"85","author":"JAG Whitworth","year":"1991","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"pntd.0009489.ref080","first-page":"335","article-title":"Increase in mortality associated with blindness in rural Africa","volume":"69","author":"HR Taylor","year":"1991","journal-title":"Bull World Health Organ"},{"key":"pntd.0009489.ref081","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/S0140-6736(04)16151-5","article-title":"Association between microfilarial load and excess mortality in onchocerciasis: an epidemiological study","volume":"363","author":"MP Little","year":"2004","journal-title":"Lancet"},{"key":"pntd.0009489.ref082","doi-asserted-by":"crossref","first-page":"e1578","DOI":"10.1371\/journal.pntd.0001578","article-title":"Density-dependent mortality of the human host in onchocerciasis: relationships between microfilarial load and excess mortality","volume":"6","author":"M Walker","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0009489.ref083","doi-asserted-by":"crossref","first-page":"6953","DOI":"10.1126\/scitranslmed.aaf6953","article-title":"Nodding syndrome may be an autoimmune reaction to the parasitic worm Onchocerca volvulus","volume":"9","author":"TP Johnson","year":"2017","journal-title":"Sci Transl Med"},{"key":"pntd.0009489.ref084","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofaa206","article-title":"A second population-based cohort study in Cameroon confirms the temporal relationship between onchocerciasis and epilepsy","volume":"7","author":"CB Chesnais","year":"2020","journal-title":"Open Forum Infect Dis"}],"updated-by":[{"DOI":"10.1371\/journal.pntd.0009489","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T00:00:00Z","timestamp":1624406400000}}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0009489","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T20:11:00Z","timestamp":1624479060000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0009489"}},"subtitle":[],"editor":[{"given":"Keke C.","family":"Fairfax","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,6,11]]},"references-count":84,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,6,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0009489","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.pntd.0009489","asserted-by":"object"}]},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,11]]}}}